William Blair Issues Pessimistic Forecast for OPCH Earnings

Option Care Health, Inc. (NASDAQ:OPCH) – Research analysts at William Blair decreased their FY2024 earnings per share (EPS) estimates for Option Care Health in a research report issued on Thursday, October 31st. William Blair analyst M. Larew now anticipates that the company will earn $1.18 per share for the year, down from their prior forecast of $1.20. The consensus estimate for Option Care Health’s current full-year earnings is $1.23 per share. William Blair also issued estimates for Option Care Health’s Q4 2025 earnings at $0.35 EPS and FY2025 earnings at $1.25 EPS.

A number of other research firms also recently commented on OPCH. Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $27.00 target price for the company. in a research report on Monday. JMP Securities increased their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, Barrington Research cut their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $22.49 on Monday. The company has a market cap of $3.83 billion, a price-to-earnings ratio of 18.90, a PEG ratio of 1.74 and a beta of 1.32. Option Care Health has a fifty-two week low of $22.46 and a fifty-two week high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.36 and a current ratio of 1.73. The stock has a fifty day moving average price of $30.31 and a 200-day moving average price of $29.85.

Insider Buying and Selling

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Option Care Health

Institutional investors have recently added to or reduced their stakes in the business. UMB Bank n.a. raised its stake in shares of Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after acquiring an additional 750 shares during the last quarter. GAMMA Investing LLC raised its position in Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. raised its position in Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares during the last quarter. SageView Advisory Group LLC acquired a new position in Option Care Health during the 1st quarter worth about $85,000. Finally, International Assets Investment Management LLC grew its position in shares of Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.